Company Curis, Inc. Nasdaq
Equities
US2312691015
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Discovery and Development of Innovative Drug
100.0
%
| 10 | 100.0 % | 10 | 100.0 % | -1.37% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 10 | 100.0 % | 10 | 100.0 % | -1.37% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Dentzer
CEO | Chief Executive Officer | 57 | 29/16/29 |
Diantha Duvall
DFI | Director of Finance/CFO | 52 | 26/22/26 |
Chief Tech/Sci/R&D Officer | - | 03/22/03 | |
Chief Tech/Sci/R&D Officer | - | 13/19/13 | |
Robert Martell
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/11/01 |
Mark W. Noel
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/01/01 |
Rachel Blasbalg
HRO | Human Resources Officer | - | 01/04/01 |
Dora Ferrari
PRN | Corporate Officer/Principal | - | 03/21/03 |
Nancy Soohoo
LAW | General Counsel | - | 01/03/01 |
Jonathan Zung
PRN | Corporate Officer/Principal | 59 | 01/23/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kenneth Kaitin
BRD | Director/Board Member | 71 | 01/03/01 |
Martyn Greenacre
CHM | Chairman | 82 | 14/00/14 |
James Dentzer
CEO | Chief Executive Officer | 57 | 29/16/29 |
Marc Rubin
BRD | Director/Board Member | 69 | 03/10/03 |
Robert Martell
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/11/01 |
Anne Borgman
BRD | Director/Board Member | 56 | 01/22/01 |
John Hohneker
BRD | Director/Board Member | 64 | 02/21/02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,894,085 | 5,883,204 ( 99.82 %) | 0 | 99.82 % |
Company contact information
![address Curis, Inc.](https://cdn.zonebourse.com/static/address/8898.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+17.72% | 44.44B | |
-10.33% | 37.99B | |
+37.55% | 37.75B | |
+29.36% | 30.78B | |
-8.44% | 27.38B | |
+12.45% | 26.17B | |
+44.19% | 14.15B | |
+31.93% | 12.59B | |
-7.67% | 11.28B |